Tsanov, Kaloyan M.
Pearson, Daniel S.
Wu, Zhaoting
Han, Areum
Triboulet, Robinson
Seligson, Marc T.
Powers, John T.
Osborne, Jihan K.
Kane, Susan
Gygi, Steven P.
Gregory, Richard I.
Daley, George Q.
Article History
Received: 1 July 2016
Accepted: 15 November 2016
First Online: 19 December 2016
Competing interests
: G.Q.D. and R.I.G. hold options and intellectual property related to 28/7 Therapeutics, a company seeking to develop inhibitors of the LIN28/<i>let-7</i> pathway. S.K. is an employee of Cell Signaling Technology.